Jonathan C. Roberts - 27 Jan 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & Chief Operating Officer
Signature
Jonathan C. Roberts
Issuer symbol
CVS
Transactions as of
27 Jan 2022
Transactions value $
-$358,846
Form type
4
Filing time
28 Jan 2022, 15:58:03
Previous filing
05 Nov 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $7M +68.5K +63.93% $102.26 176K 27 Jan 2022 Direct
transaction CVS Common Stock Sale -$7.36M -68.5K -39% $107.50 107K 27 Jan 2022 Direct F1
holding CVS Common Stock 34.7K 27 Jan 2022 By GRAT
holding CVS Common Stock (restricted) 12.8K 27 Jan 2022 Direct
holding CVS ESOP Common Stock 6.05K 27 Jan 2022 By ESOP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -68.5K -100% $0.00* 0 27 Jan 2022 Common Stock 68.5K $102.26 Direct F2
holding CVS Phantom Stock Credits 1.42K 27 Jan 2022 Common Stock 1.42K $1.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.